4//SEC Filing
Nohaile Michael 4
Accession 0001209191-22-045293
CIK 0001674930other
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 6:08 PM ET
Size
7.6 KB
Accession
0001209191-22-045293
Insider Transaction Report
Form 4
Nohaile Michael
Director
Transactions
- Award
Common Stock
2022-08-01+4,000→ 4,000 total - Award
Stock Option (Right to Buy)
2022-08-01+10,000→ 10,000 totalExercise: $59.54Exp: 2032-07-31→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after August 1, 2022, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date.
- [F2]The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after August 1, 2022, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date.
Documents
Issuer
Fulgent Genetics, Inc.
CIK 0001674930
Entity typeother
Related Parties
1- filerCIK 0001890563
Filing Metadata
- Form type
- 4
- Filed
- Aug 9, 8:00 PM ET
- Accepted
- Aug 10, 6:08 PM ET
- Size
- 7.6 KB